Full Length Research Paper
References
|
Al-Sabah S, Donnelly D (2003). The positive charge at Lys-288 of the glucagon-like peptide-1 (GLP-1) receptor is important for binding the N-terminus of peptide agonists. FEBS Lett. 553:342-346. |
|
|
Arko B, Prezelj J, Kocijancic A, Komel R, Marc J (2005). Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women. Maturitas 51:270-279. |
|
|
Bavec A, Hällbrink M, Langel U, Zorko M (2003). Different role of intracellular loops of glucagon-like peptide-1 receptor in G-protein coupling. Regul. Pept. 111:137-144. |
|
|
Beinborn M, Worrall CI, McBride EW, Kopin AS (2005). A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness. Regul. Pept. 130:1-6. |
|
|
Drucker DJ (1998). Glucagon-like peptides. Diabetes 47:159-169. |
|
|
Fortin JP, Schroeder JC, Zhu Y, Beinborn M, Kopin AS (2010). Pharmacological characterization of human incretin receptor missense variants. J. Pharmacol. Exp. Ther. 332:274-280. |
|
|
Gennari L, Merlotti D, De Paola V, Calabro A, Becherini L, Martini G, Nuti R (2005). Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am. J. Epidemiol. 161:307-320. |
|
|
Horst-Sikorska W, Dytfeld J, Wawrzyniak A, Marcinkowska M, Michalak M, Franek E, Napiórkowska L, DrwÄ™ska N, SÅ‚omski R (2013). Vitamin D receptor gene polymorphisms, bone mineral density and fractures in postmenopausal women with osteoporosis. Mol. Biol. Rep. 40:383-390. |
|
|
Isales CM, Hamrick M (2008). Nutritional hormones and the entero-osseous axis. J. Musculoskelet. Neuronal. Interact. 8:348-350. |
|
|
Jouanny P, Guillemin F, Kuntz C, Jeandel C, Pourel J (1995).Environmental and genetic factors affecting bone mass. Similarity of bone density among members of healthy families. Arthritis Rheum. 38:61-67. |
|
|
Kieffer TJ, Habener JF (1999). The glucagon-like peptides. Endocr Rev 20:876-913. |
|
|
Lee HJ, Kim H, Ku SY, Choi YM, Kim JH, Kim JG (2014). Association between polymorphisms in leptin, leptin receptor, and A-adrenergic receptor genes and bone mineral density in postmenopausal Korean women. Menopause 21:67-73. |
|
|
Lopez de Maturana R, Donnelly D (2002). The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge. FEBS Lett. 530: 244-248. |
|
|
Lopez de Maturana R, Treece-Birch J, Abidi F, Findlay JB, Donnelly D (2004). Met-204 and Tyr-205 are together important for binding GLP-1 receptor agonists but not their N-terminally truncated analogues. Prot. Peptide Lett. 11:15-22. |
|
|
Ma X, Meng J, Jia M, Bi L, Zhou Y, Wang Y, Hu J, He G, Luo X (2013). Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats. J. Bone Miner Res. 28:1641-1652. |
|
|
NIH (2001). Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy: Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785-795. |
|
|
Riggs BL, Melton III LJ (1986). Involutional osteoporosis. N Engl. J. Med. 314:1676-1686. |
|
|
Sathananthan A, Man CD, Micheletto F, Zinsmeister AR, Camilleri M, Giesler PD, Laugen JM, Toffolo G, Rizza RA, Cobelli C, Vella A (2010). Common Genetic Variation in GLP1R and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects. Diabetes Care 33:2074-2076. |
|
|
Sheikh HI, Dougherty LR, Hayden EP, Klein DN, Singh SM (2010). Glucagon-like peptide-1 receptor gene polymorphism (Leu260Phe) is associated with morning cortisol in preschoolers. Prog. Neuropsychopharmacol. Biol. Psychiatr. 34:980-983. |
|
|
Wang Q, Chen Z, Huang Y, Li Q, Zhu L, Cai X, He G, Xie Y, Liu Q (2013). The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women. Int. Immunopharmacol. 17:404-407. |
|
|
Xiao Q, Jeng W, Wheeler MB (2000). Characterization of glucagon-like peptide-1 receptor-binding determinants. J. Mol. Endocrinol. 25: 321-335. |
|
|
Yamada C, Yamada Y, Tsukiyama K, Yamada K, Udagawa N, Takahashi N, Tanaka K, Drucker DJ, Seino Y, Inagaki N (2008). The murine glucagon-like peptide-1 receptor is essential for control of bone resorption. Endocrinol. 149:574-579. |
|
|
Zhao HY, Liu JM, Ning G, Zhao YJ, Zhang LZ, Sun LH, Xu MY, Uitterlinden AG, Chen JL (2005). The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. Osteoporos. Int. 16:1519-1524. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
